{"GETRequest":[{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":637,"format_numeric":"4,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(4)dHex(1)","format_condensed":"H4N5F1","mass":1828.7029,"mass_monoisotopic":1827.6767,"reviewed":true,"glytoucan_id":"G03382KH"},"structure":{"id":11124,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":742,"format_numeric":"3,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(3)dHex(1)","format_condensed":"H3N4F1","mass":1463.3655,"mass_monoisotopic":1462.5445,"reviewed":true,"glytoucan_id":"G49874UX"},"structure":{"id":2967,"glytoucan_id":"G80858MF","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":35,"format_numeric":"5,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(5)dHex(1)","format_condensed":"H5N5F1","mass":1990.8453,"mass_monoisotopic":1989.7295,"reviewed":true,"glytoucan_id":"G91636VS"},"structure":{"id":11154,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2983,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":35,"format_numeric":"5,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(5)dHex(1)","format_condensed":"H5N5F1","mass":1990.8453,"mass_monoisotopic":1989.7295,"reviewed":true,"glytoucan_id":"G91636VS"},"structure":{"id":11154,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":762,"format_numeric":"6,3,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:6 HexNAc:3 dHex:1","format_byonic":"HexNAc(3)Hex(6)dHex(1)","format_condensed":"H6N3F1","mass":1746.5977,"mass_monoisotopic":1745.6235,"reviewed":true,"glytoucan_id":"G84820NF"},"structure":{"id":11109,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Hybrid"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2976,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab)","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":350,"format_numeric":"4,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(4)dHex(1)","format_condensed":"H4N4F1","mass":1625.5079,"mass_monoisotopic":1624.5973,"reviewed":true,"glytoucan_id":"G46687AB"},"structure":{"id":11110,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":603,"format_numeric":"6,2,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:6 HexNAc:2","format_byonic":"HexNAc(2)Hex(6)","format_condensed":"H6N2","mass":1397.2597,"mass_monoisotopic":1396.4862,"reviewed":true,"glytoucan_id":"G39188ZX"},"structure":{"id":2039,"glytoucan_id":"G80966KZ","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"High-Mannose"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2983,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":603,"format_numeric":"6,2,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:6 HexNAc:2","format_byonic":"HexNAc(2)Hex(6)","format_condensed":"H6N2","mass":1397.2597,"mass_monoisotopic":1396.4862,"reviewed":true,"glytoucan_id":"G39188ZX"},"structure":{"id":2039,"glytoucan_id":"G80966KZ","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"High-Mannose"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":35,"format_numeric":"5,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(5)dHex(1)","format_condensed":"H5N5F1","mass":1990.8453,"mass_monoisotopic":1989.7295,"reviewed":true,"glytoucan_id":"G91636VS"},"structure":{"id":11154,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":676,"format_numeric":"5,4,1,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1 NeuAc:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)NeuAc(1)","format_condensed":"H5N4F1S1","mass":2078.9082,"mass_monoisotopic":2077.7455,"reviewed":true,"glytoucan_id":"G84452RH"},"structure":{"id":11123,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2985,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":637,"format_numeric":"4,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(4)dHex(1)","format_condensed":"H4N5F1","mass":1828.7029,"mass_monoisotopic":1827.6767,"reviewed":true,"glytoucan_id":"G03382KH"},"structure":{"id":11124,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7715,"sequence":"SLSSVVTVPSSSLGTQTY","length":18}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":89,"format_numeric":"6,3,0,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:6 HexNAc:3 NeuAc:1","format_byonic":"HexNAc(3)Hex(6)NeuAc(1)","format_condensed":"H6N3S1","mass":1891.7126,"mass_monoisotopic":1890.661,"reviewed":true,"glytoucan_id":"G23294PN"},"structure":{"id":1823,"glytoucan_id":"G92570PJ","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Hybrid"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2976,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab)","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":205,"format_numeric":"5,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)","format_condensed":"H5N4F1","mass":1787.6503,"mass_monoisotopic":1786.6501,"reviewed":true,"glytoucan_id":"G23863VK"},"structure":{"id":1860,"glytoucan_id":"G78059CC","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":205,"format_numeric":"5,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)","format_condensed":"H5N4F1","mass":1787.6503,"mass_monoisotopic":1786.6501,"reviewed":true,"glytoucan_id":"G23863VK"},"structure":{"id":1860,"glytoucan_id":"G78059CC","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":205,"format_numeric":"5,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)","format_condensed":"H5N4F1","mass":1787.6503,"mass_monoisotopic":1786.6501,"reviewed":true,"glytoucan_id":"G23863VK"},"structure":{"id":1860,"glytoucan_id":"G78059CC","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2981,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":742,"format_numeric":"3,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(3)dHex(1)","format_condensed":"H3N4F1","mass":1463.3655,"mass_monoisotopic":1462.5445,"reviewed":true,"glytoucan_id":"G49874UX"},"structure":{"id":2967,"glytoucan_id":"G80858MF","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":161,"format_numeric":"5,3,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:3 dHex:1","format_byonic":"HexNAc(3)Hex(5)dHex(1)","format_condensed":"H5N3F1","mass":1584.4553,"mass_monoisotopic":1583.5707,"reviewed":true,"glytoucan_id":"G82119TF"},"structure":{"id":9591,"reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Hybrid"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":676,"format_numeric":"5,4,1,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1 NeuAc:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)NeuAc(1)","format_condensed":"H5N4F1S1","mass":2078.9082,"mass_monoisotopic":2077.7455,"reviewed":true,"glytoucan_id":"G84452RH"},"structure":{"id":11123,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":37,"format_numeric":"4,5,2,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:2","format_byonic":"HexNAc(5)Hex(4)dHex(2)","format_condensed":"H4N5F2","mass":1974.8459,"mass_monoisotopic":1973.7346,"reviewed":true,"glytoucan_id":"G70418MS"},"structure":{"id":11152,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2980,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L115N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":649,"format_numeric":"9,2,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:9 HexNAc:2","format_byonic":"HexNAc(2)Hex(9)","format_condensed":"H9N2","mass":1883.6869,"mass_monoisotopic":1882.6446,"reviewed":true,"glytoucan_id":"G70101JE"},"structure":{"id":2472,"glytoucan_id":"G60230HH","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"High-Mannose"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":489,"format_numeric":"4,5,1,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:1 NeuAc:1","format_byonic":"HexNAc(5)Hex(4)dHex(1)NeuAc(1)","format_condensed":"H4N5F1S1","mass":2119.9608,"mass_monoisotopic":2118.7721,"reviewed":true,"glytoucan_id":"G72667IM"},"structure":{"id":11253,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2983,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":637,"format_numeric":"4,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(4)dHex(1)","format_condensed":"H4N5F1","mass":1828.7029,"mass_monoisotopic":1827.6767,"reviewed":true,"glytoucan_id":"G03382KH"},"structure":{"id":11124,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2979,"name":"Immunoglobulin kappa light chain (Trastuzumab) mutant Q160N","reviewed":true,"uniprots":[{"uniprot_acc":"P0DOX7","uniprot_id":"IGK_HUMAN"}]},"composition":{"id":350,"format_numeric":"4,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(4)dHex(1)","format_condensed":"H4N4F1","mass":1625.5079,"mass_monoisotopic":1624.5973,"reviewed":true,"glytoucan_id":"G46687AB"},"structure":{"id":11110,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2983,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":676,"format_numeric":"5,4,1,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1 NeuAc:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)NeuAc(1)","format_condensed":"H5N4F1S1","mass":2078.9082,"mass_monoisotopic":2077.7455,"reviewed":true,"glytoucan_id":"G84452RH"},"structure":{"id":11123,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2980,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L115N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":35,"format_numeric":"5,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(5)dHex(1)","format_condensed":"H5N5F1","mass":1990.8453,"mass_monoisotopic":1989.7295,"reviewed":true,"glytoucan_id":"G91636VS"},"structure":{"id":11154,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2981,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":35,"format_numeric":"5,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(5)dHex(1)","format_condensed":"H5N5F1","mass":1990.8453,"mass_monoisotopic":1989.7295,"reviewed":true,"glytoucan_id":"G91636VS"},"structure":{"id":11154,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2981,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":89,"format_numeric":"6,3,0,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:6 HexNAc:3 NeuAc:1","format_byonic":"HexNAc(3)Hex(6)NeuAc(1)","format_condensed":"H6N3S1","mass":1891.7126,"mass_monoisotopic":1890.661,"reviewed":true,"glytoucan_id":"G23294PN"},"structure":{"id":1823,"glytoucan_id":"G92570PJ","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Hybrid"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":318,"format_numeric":"4,5,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5","format_byonic":"HexNAc(5)Hex(4)","format_condensed":"H4N5","mass":1682.5599,"mass_monoisotopic":1681.6188,"reviewed":true,"glytoucan_id":"G23432EQ"},"structure":{"id":11227,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2980,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L115N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":676,"format_numeric":"5,4,1,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1 NeuAc:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)NeuAc(1)","format_condensed":"H5N4F1S1","mass":2078.9082,"mass_monoisotopic":2077.7455,"reviewed":true,"glytoucan_id":"G84452RH"},"structure":{"id":11123,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":393,"format_numeric":"5,4,0,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 NeuAc:1","format_byonic":"HexNAc(4)Hex(5)NeuAc(1)","format_condensed":"H5N4S1","mass":1932.7652,"mass_monoisotopic":1931.6876,"reviewed":true,"glytoucan_id":"G06356OH"},"structure":{"id":10835,"glytoucan_id":"G94239KE","reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2983,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":205,"format_numeric":"5,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)","format_condensed":"H5N4F1","mass":1787.6503,"mass_monoisotopic":1786.6501,"reviewed":true,"glytoucan_id":"G23863VK"},"structure":{"id":1860,"glytoucan_id":"G78059CC","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2981,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":489,"format_numeric":"4,5,1,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:1 NeuAc:1","format_byonic":"HexNAc(5)Hex(4)dHex(1)NeuAc(1)","format_condensed":"H4N5F1S1","mass":2119.9608,"mass_monoisotopic":2118.7721,"reviewed":true,"glytoucan_id":"G72667IM"},"structure":{"id":11253,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":11,"format_numeric":"5,2,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:2","format_byonic":"HexNAc(2)Hex(5)","format_condensed":"H5N2","mass":1235.1173,"mass_monoisotopic":1234.4334,"reviewed":true,"glytoucan_id":"G06110VR"},"structure":{"id":1443,"glytoucan_id":"G55220VL","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"High-Mannose"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":11,"format_numeric":"5,2,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:2","format_byonic":"HexNAc(2)Hex(5)","format_condensed":"H5N2","mass":1235.1173,"mass_monoisotopic":1234.4334,"reviewed":true,"glytoucan_id":"G06110VR"},"structure":{"id":1443,"glytoucan_id":"G55220VL","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"High-Mannose"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2981,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":350,"format_numeric":"4,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(4)dHex(1)","format_condensed":"H4N4F1","mass":1625.5079,"mass_monoisotopic":1624.5973,"reviewed":true,"glytoucan_id":"G46687AB"},"structure":{"id":11110,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2983,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":11,"format_numeric":"5,2,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:2","format_byonic":"HexNAc(2)Hex(5)","format_condensed":"H5N2","mass":1235.1173,"mass_monoisotopic":1234.4334,"reviewed":true,"glytoucan_id":"G06110VR"},"structure":{"id":1443,"glytoucan_id":"G55220VL","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"High-Mannose"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":691,"format_numeric":"8,2,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:8 HexNAc:2","format_byonic":"HexNAc(2)Hex(8)","format_condensed":"H8N2","mass":1721.5445,"mass_monoisotopic":1720.5918,"reviewed":true,"glytoucan_id":"G64527OM"},"structure":{"id":362,"glytoucan_id":"G40702WU","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"High-Mannose"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2980,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L115N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":350,"format_numeric":"4,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(4)dHex(1)","format_condensed":"H4N4F1","mass":1625.5079,"mass_monoisotopic":1624.5973,"reviewed":true,"glytoucan_id":"G46687AB"},"structure":{"id":11110,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":89,"format_numeric":"6,3,0,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:6 HexNAc:3 NeuAc:1","format_byonic":"HexNAc(3)Hex(6)NeuAc(1)","format_condensed":"H6N3S1","mass":1891.7126,"mass_monoisotopic":1890.661,"reviewed":true,"glytoucan_id":"G23294PN"},"structure":{"id":1823,"glytoucan_id":"G92570PJ","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Hybrid"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":558,"format_numeric":"6,3,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:6 HexNAc:3","format_byonic":"HexNAc(3)Hex(6)","format_condensed":"H6N3","mass":1600.4547,"mass_monoisotopic":1599.5656,"reviewed":true,"glytoucan_id":"G72735IY"},"structure":{"id":70,"glytoucan_id":"G16828VN","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Hybrid"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":628,"format_numeric":"5,3,0,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:3 NeuAc:1","format_byonic":"HexNAc(3)Hex(5)NeuAc(1)","format_condensed":"H5N3S1","mass":1729.5702,"mass_monoisotopic":1728.6082,"reviewed":true,"glytoucan_id":"G82463GQ"},"structure":{"id":11125,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Hybrid"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2985,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":35,"format_numeric":"5,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(5)dHex(1)","format_condensed":"H5N5F1","mass":1990.8453,"mass_monoisotopic":1989.7295,"reviewed":true,"glytoucan_id":"G91636VS"},"structure":{"id":11154,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7715,"sequence":"SLSSVVTVPSSSLGTQTY","length":18}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2981,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":37,"format_numeric":"4,5,2,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:2","format_byonic":"HexNAc(5)Hex(4)dHex(2)","format_condensed":"H4N5F2","mass":1974.8459,"mass_monoisotopic":1973.7346,"reviewed":true,"glytoucan_id":"G70418MS"},"structure":{"id":11152,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2981,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":676,"format_numeric":"5,4,1,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1 NeuAc:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)NeuAc(1)","format_condensed":"H5N4F1S1","mass":2078.9082,"mass_monoisotopic":2077.7455,"reviewed":true,"glytoucan_id":"G84452RH"},"structure":{"id":11123,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2980,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L115N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":742,"format_numeric":"3,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(3)dHex(1)","format_condensed":"H3N4F1","mass":1463.3655,"mass_monoisotopic":1462.5445,"reviewed":true,"glytoucan_id":"G49874UX"},"structure":{"id":2967,"glytoucan_id":"G80858MF","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2979,"name":"Immunoglobulin kappa light chain (Trastuzumab) mutant Q160N","reviewed":true,"uniprots":[{"uniprot_acc":"P0DOX7","uniprot_id":"IGK_HUMAN"}]},"composition":{"id":742,"format_numeric":"3,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(3)dHex(1)","format_condensed":"H3N4F1","mass":1463.3655,"mass_monoisotopic":1462.5445,"reviewed":true,"glytoucan_id":"G49874UX"},"structure":{"id":2967,"glytoucan_id":"G80858MF","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":350,"format_numeric":"4,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(4)dHex(1)","format_condensed":"H4N4F1","mass":1625.5079,"mass_monoisotopic":1624.5973,"reviewed":true,"glytoucan_id":"G46687AB"},"structure":{"id":11110,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2985,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":676,"format_numeric":"5,4,1,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1 NeuAc:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)NeuAc(1)","format_condensed":"H5N4F1S1","mass":2078.9082,"mass_monoisotopic":2077.7455,"reviewed":true,"glytoucan_id":"G84452RH"},"structure":{"id":11123,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7715,"sequence":"SLSSVVTVPSSSLGTQTY","length":18}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2981,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":205,"format_numeric":"5,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)","format_condensed":"H5N4F1","mass":1787.6503,"mass_monoisotopic":1786.6501,"reviewed":true,"glytoucan_id":"G23863VK"},"structure":{"id":1860,"glytoucan_id":"G78059CC","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2979,"name":"Immunoglobulin kappa light chain (Trastuzumab) mutant Q160N","reviewed":true,"uniprots":[{"uniprot_acc":"P0DOX7","uniprot_id":"IGK_HUMAN"}]},"composition":{"id":205,"format_numeric":"5,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)","format_condensed":"H5N4F1","mass":1787.6503,"mass_monoisotopic":1786.6501,"reviewed":true,"glytoucan_id":"G23863VK"},"structure":{"id":1860,"glytoucan_id":"G78059CC","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":500,"format_numeric":"3,4,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:4","format_byonic":"HexNAc(4)Hex(3)","format_condensed":"H3N4","mass":1317.2225,"mass_monoisotopic":1316.4866,"reviewed":true},"structure":{"id":3258,"glytoucan_id":"G39213VZ","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2985,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":742,"format_numeric":"3,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(3)dHex(1)","format_condensed":"H3N4F1","mass":1463.3655,"mass_monoisotopic":1462.5445,"reviewed":true,"glytoucan_id":"G49874UX"},"structure":{"id":2967,"glytoucan_id":"G80858MF","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7715,"sequence":"SLSSVVTVPSSSLGTQTY","length":18}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2983,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":350,"format_numeric":"4,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(4)dHex(1)","format_condensed":"H4N4F1","mass":1625.5079,"mass_monoisotopic":1624.5973,"reviewed":true,"glytoucan_id":"G46687AB"},"structure":{"id":11110,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":637,"format_numeric":"4,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(4)dHex(1)","format_condensed":"H4N5F1","mass":1828.7029,"mass_monoisotopic":1827.6767,"reviewed":true,"glytoucan_id":"G03382KH"},"structure":{"id":11124,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2985,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":489,"format_numeric":"4,5,1,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:1 NeuAc:1","format_byonic":"HexNAc(5)Hex(4)dHex(1)NeuAc(1)","format_condensed":"H4N5F1S1","mass":2119.9608,"mass_monoisotopic":2118.7721,"reviewed":true,"glytoucan_id":"G72667IM"},"structure":{"id":11253,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7715,"sequence":"SLSSVVTVPSSSLGTQTY","length":18}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2976,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab)","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":742,"format_numeric":"3,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(3)dHex(1)","format_condensed":"H3N4F1","mass":1463.3655,"mass_monoisotopic":1462.5445,"reviewed":true,"glytoucan_id":"G49874UX"},"structure":{"id":2967,"glytoucan_id":"G80858MF","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":742,"format_numeric":"3,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(3)dHex(1)","format_condensed":"H3N4F1","mass":1463.3655,"mass_monoisotopic":1462.5445,"reviewed":true,"glytoucan_id":"G49874UX"},"structure":{"id":2967,"glytoucan_id":"G80858MF","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":749,"format_numeric":"3,5,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:5","format_byonic":"HexNAc(5)Hex(3)","format_condensed":"H3N5","mass":1520.4175,"mass_monoisotopic":1519.566,"reviewed":true,"glytoucan_id":"G31936TA"},"structure":{"id":1604,"glytoucan_id":"G32611KT","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2984,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":350,"format_numeric":"4,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(4)dHex(1)","format_condensed":"H4N4F1","mass":1625.5079,"mass_monoisotopic":1624.5973,"reviewed":true,"glytoucan_id":"G46687AB"},"structure":{"id":11110,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2982,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":393,"format_numeric":"5,4,0,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 NeuAc:1","format_byonic":"HexNAc(4)Hex(5)NeuAc(1)","format_condensed":"H5N4S1","mass":1932.7652,"mass_monoisotopic":1931.6876,"reviewed":true,"glytoucan_id":"G06356OH"},"structure":{"id":10835,"glytoucan_id":"G94239KE","reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2981,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":637,"format_numeric":"4,5,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:5 dHex:1","format_byonic":"HexNAc(5)Hex(4)dHex(1)","format_condensed":"H4N5F1","mass":1828.7029,"mass_monoisotopic":1827.6767,"reviewed":true,"glytoucan_id":"G03382KH"},"structure":{"id":11124,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2985,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":350,"format_numeric":"4,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:4 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(4)dHex(1)","format_condensed":"H4N4F1","mass":1625.5079,"mass_monoisotopic":1624.5973,"reviewed":true,"glytoucan_id":"G46687AB"},"structure":{"id":11110,"reviewed":false,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7715,"sequence":"SLSSVVTVPSSSLGTQTY","length":18}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2985,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":205,"format_numeric":"5,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)","format_condensed":"H5N4F1","mass":1787.6503,"mass_monoisotopic":1786.6501,"reviewed":true,"glytoucan_id":"G23863VK"},"structure":{"id":1860,"glytoucan_id":"G78059CC","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7715,"sequence":"SLSSVVTVPSSSLGTQTY","length":18}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2983,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":558,"format_numeric":"6,3,0,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:6 HexNAc:3","format_byonic":"HexNAc(3)Hex(6)","format_condensed":"H6N3","mass":1600.4547,"mass_monoisotopic":1599.5656,"reviewed":true,"glytoucan_id":"G72735IY"},"structure":{"id":70,"glytoucan_id":"G16828VN","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Hybrid"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2985,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":89,"format_numeric":"6,3,0,1,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:6 HexNAc:3 NeuAc:1","format_byonic":"HexNAc(3)Hex(6)NeuAc(1)","format_condensed":"H6N3S1","mass":1891.7126,"mass_monoisotopic":1890.661,"reviewed":true,"glytoucan_id":"G23294PN"},"structure":{"id":1823,"glytoucan_id":"G92570PJ","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Hybrid"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7715,"sequence":"SLSSVVTVPSSSLGTQTY","length":18}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2983,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":742,"format_numeric":"3,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:3 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(3)dHex(1)","format_condensed":"H3N4F1","mass":1463.3655,"mass_monoisotopic":1462.5445,"reviewed":true,"glytoucan_id":"G49874UX"},"structure":{"id":2967,"glytoucan_id":"G80858MF","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}],"peptides":[{"id":7714,"sequence":"NSGALTSGVHTFPAVLQSSGLY","length":22}]},{"taxonomy":{"id":227,"species":"Homo sapiens","common_name":"Human","taxonomy_id":"9606"},"protein":{"id":2980,"name":"Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L115N","reviewed":true,"uniprots":[{"uniprot_acc":"P01857","uniprot_id":"IGHG1_HUMAN","nextprot":"NX_P01857","genecards":"IGHG1","glygen":"P01857"}]},"composition":{"id":205,"format_numeric":"5,4,1,0,0,0,0,0,0,0,0,0,0,0","format_glyconnect":"Hex:5 HexNAc:4 dHex:1","format_byonic":"HexNAc(4)Hex(5)dHex(1)","format_condensed":"H5N4F1","mass":1787.6503,"mass_monoisotopic":1786.6501,"reviewed":true,"glytoucan_id":"G23863VK"},"structure":{"id":1860,"glytoucan_id":"G78059CC","reviewed":true,"is_undefined":false,"has_image":true,"glycan_type":"N-Linked","glycan_core":"Complex"},"source":{"cell_line":{"id":158,"name":"HEK293-F","cellosaurus_id":"CVCL_6642","is_problematic":false}},"references":[{"id":2990,"title":"Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.","authors":"Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V","pmid":34834161,"doi":"10.3390/pharmaceutics13111747","year":2021}]}],"POSTRequest":{"nodes":[{"id":"637","glytoucanId":"G03382KH","glyconnectFormat":"Hex:4 HexNAc:5 dHex:1","byonicFormat":"HexNAc(5)Hex(4)dHex(1)","condensedFormat":"H4N5F1","averageMass":1828.7029,"monoisotopicMass":1827.6767,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":5,"childCount":3,"parents":["#H4N5-H4N5F1","#H3N5-H4N5","#H3N4-H3N5","#H3N4-H3N4F1","#H4N4F1-H4N5F1","#H3N4F1-H4N4F1"],"children":["#H4N5F1-H4N5F2","#H4N5F1-H5N5F1","#H4N5F1-H4N5F1S1"],"structures":["11124"],"references":["2990"]},{"id":"89","glytoucanId":"G23294PN","glyconnectFormat":"Hex:6 HexNAc:3 NeuAc:1","byonicFormat":"HexNAc(3)Hex(6)NeuAc(1)","condensedFormat":"H6N3S1","averageMass":1891.7126,"monoisotopicMass":1890.661,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":6,"childCount":0,"parents":["#H5N2-H5N2S1","#H5N3-H5N3S1","#H5N2S1-H5N3S1","#H5N3S1-H6N3S1","#H6N2-H6N3","#H5N2-H5N3","#H5N2-H6N2","#H6N3-H6N3S1","#H5N3-H6N3"],"children":[],"structures":["1823"],"references":["2990"]},{"id":"318","glytoucanId":"G23432EQ","glyconnectFormat":"Hex:4 HexNAc:5","byonicFormat":"HexNAc(5)Hex(4)","condensedFormat":"H4N5","averageMass":1682.5599,"monoisotopicMass":1681.6188,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":2,"childCount":4,"parents":["#H3N5-H4N5","#H3N4-H3N5"],"children":["#H4N5-H4N5F1","#H4N5F1-H4N5F2","#H4N5F1-H5N5F1","#H4N5F1-H4N5F1S1"],"structures":["11227"],"references":["2990"]},{"id":"37","glytoucanId":"G70418MS","glyconnectFormat":"Hex:4 HexNAc:5 dHex:2","byonicFormat":"HexNAc(5)Hex(4)dHex(2)","condensedFormat":"H4N5F2","averageMass":1974.8459,"monoisotopicMass":1973.7346,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":6,"childCount":0,"parents":["#H4N5F1-H4N5F2","#H4N5-H4N5F1","#H3N5-H4N5","#H3N4-H3N5","#H3N4-H3N4F1","#H4N4F1-H4N5F1","#H3N4F1-H4N4F1"],"children":[],"structures":["11152"],"references":["2990"]},{"id":"489","glytoucanId":"G72667IM","glyconnectFormat":"Hex:4 HexNAc:5 dHex:1 NeuAc:1","byonicFormat":"HexNAc(5)Hex(4)dHex(1)NeuAc(1)","condensedFormat":"H4N5F1S1","averageMass":2119.9608,"monoisotopicMass":2118.7721,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":6,"childCount":0,"parents":["#H4N5-H4N5F1","#H3N5-H4N5","#H3N4-H3N5","#H3N4-H3N4F1","#H4N4F1-H4N5F1","#H3N4F1-H4N4F1","#H4N5F1-H4N5F1S1"],"children":[],"structures":["11253"],"references":["2990"]},{"id":"350","glytoucanId":"G46687AB","glyconnectFormat":"Hex:4 HexNAc:4 dHex:1","byonicFormat":"HexNAc(4)Hex(4)dHex(1)","condensedFormat":"H4N4F1","averageMass":1625.5079,"monoisotopicMass":1624.5973,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":2,"childCount":6,"parents":["#H3N4-H3N4F1","#H3N4F1-H4N4F1"],"children":["#H4N5F1-H4N5F2","#H5N4F1-H5N4F1S1","#H4N5F1-H5N5F1","#H4N4F1-H5N4F1","#H4N4F1-H4N5F1","#H5N4F1-H5N5F1","#H4N5F1-H4N5F1S1"],"structures":["11110"],"references":["2990"]},{"id":"749","glytoucanId":"G31936TA","glyconnectFormat":"Hex:3 HexNAc:5","byonicFormat":"HexNAc(5)Hex(3)","condensedFormat":"H3N5","averageMass":1520.4175,"monoisotopicMass":1519.566,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":1,"childCount":5,"parents":["#H3N4-H3N5"],"children":["#H4N5-H4N5F1","#H4N5F1-H4N5F2","#H4N5F1-H5N5F1","#H3N5-H4N5","#H4N5F1-H4N5F1S1"],"structures":["1604"],"references":["2990"]},{"id":"500","glytoucanId":"","glyconnectFormat":"Hex:3 HexNAc:4","byonicFormat":"HexNAc(4)Hex(3)","condensedFormat":"H3N4","averageMass":1317.2225,"monoisotopicMass":1316.4866,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":0,"childCount":10,"parents":[],"children":["#H4N5-H4N5F1","#H4N5F1-H4N5F2","#H5N4F1-H5N4F1S1","#H4N5F1-H5N5F1","#H3N5-H4N5","#H4N4F1-H5N4F1","#H3N4-H3N5","#H3N4-H3N4F1","#H4N4F1-H4N5F1","#H5N4F1-H5N5F1","#H3N4F1-H4N4F1","#H4N5F1-H4N5F1S1"],"structures":["3258"],"references":["2990"]},{"id":"676","glytoucanId":"G84452RH","glyconnectFormat":"Hex:5 HexNAc:4 dHex:1 NeuAc:1","byonicFormat":"HexNAc(4)Hex(5)dHex(1)NeuAc(1)","condensedFormat":"H5N4F1S1","averageMass":2078.9082,"monoisotopicMass":2077.7455,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":11,"childCount":0,"parents":["#H5N4F1-H5N4F1S1","#H5N2-H5N2S1","#H5N3-H5N3S1","#H5N2S1-H5N3S1","#H4N4F1-H5N4F1","#H5N2F1-H5N3F1","#H3N4-H3N4F1","#H5N4S1-H5N4F1S1","#H5N3F1-H5N4F1","#H5N2-H5N3","#H5N3S1-H5N4S1","#H3N4F1-H4N4F1","#H5N2-H5N2F1","#H5N3-H5N3F1"],"children":[],"structures":["11123"],"references":["2990"]},{"id":"161","glytoucanId":"G82119TF","glyconnectFormat":"Hex:5 HexNAc:3 dHex:1","byonicFormat":"HexNAc(3)Hex(5)dHex(1)","condensedFormat":"H5N3F1","averageMass":1584.4553,"monoisotopicMass":1583.5707,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":3,"childCount":4,"parents":["#H5N2F1-H5N3F1","#H5N2-H5N3","#H5N2-H5N2F1","#H5N3-H5N3F1"],"children":["#H5N4F1-H5N4F1S1","#H5N3F1-H5N4F1","#H5N4F1-H5N5F1","#H5N3F1-H6N3F1"],"structures":["9591"],"references":["2990"]},{"id":"205","glytoucanId":"G23863VK","glyconnectFormat":"Hex:5 HexNAc:4 dHex:1","byonicFormat":"HexNAc(4)Hex(5)dHex(1)","condensedFormat":"H5N4F1","averageMass":1787.6503,"monoisotopicMass":1786.6501,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":7,"childCount":2,"parents":["#H5N3F1-H5N4F1","#H4N4F1-H5N4F1","#H5N2F1-H5N3F1","#H5N2-H5N3","#H3N4-H3N4F1","#H3N4F1-H4N4F1","#H5N2-H5N2F1","#H5N3-H5N3F1"],"children":["#H5N4F1-H5N4F1S1","#H5N4F1-H5N5F1"],"structures":["1860"],"references":["2990"]},{"id":"35","glytoucanId":"G91636VS","glyconnectFormat":"Hex:5 HexNAc:5 dHex:1","byonicFormat":"HexNAc(5)Hex(5)dHex(1)","condensedFormat":"H5N5F1","averageMass":1990.8453,"monoisotopicMass":1989.7295,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":11,"childCount":0,"parents":["#H4N5-H4N5F1","#H4N4F1-H5N4F1","#H5N2F1-H5N3F1","#H3N4-H3N5","#H3N4-H3N4F1","#H4N4F1-H4N5F1","#H5N4F1-H5N5F1","#H4N5F1-H5N5F1","#H3N5-H4N5","#H5N3F1-H5N4F1","#H5N2-H5N3","#H3N4F1-H4N4F1","#H5N2-H5N2F1","#H5N3-H5N3F1"],"children":[],"structures":["11154"],"references":["2990"]},{"id":"393","glytoucanId":"G06356OH","glyconnectFormat":"Hex:5 HexNAc:4 NeuAc:1","byonicFormat":"HexNAc(4)Hex(5)NeuAc(1)","condensedFormat":"H5N4S1","averageMass":1932.7652,"monoisotopicMass":1931.6876,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":4,"childCount":1,"parents":["#H5N2-H5N2S1","#H5N3-H5N3S1","#H5N2S1-H5N3S1","#H5N2-H5N3","#H5N3S1-H5N4S1"],"children":["#H5N4S1-H5N4F1S1"],"structures":["10835"],"references":["2990"]},{"id":"11","glytoucanId":"G06110VR","glyconnectFormat":"Hex:5 HexNAc:2","byonicFormat":"HexNAc(2)Hex(5)","condensedFormat":"H5N2","averageMass":1235.1173,"monoisotopicMass":1234.4334,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":0,"childCount":16,"parents":[],"children":["#H5N4F1-H5N4F1S1","#H5N2-H5N2S1","#H5N3-H5N3S1","#H5N2S1-H5N3S1","#H5N2F1-H5N3F1","#H5N4F1-H5N5F1","#H6N3-H6N3S1","#H5N3F1-H6N3F1","#H5N4S1-H5N4F1S1","#H5N3F1-H5N4F1","#H5N3S1-H6N3S1","#H8N2-H9N2","#H7N2-H8N2","#H6N2-H7N2","#H6N2-H6N3","#H5N2-H5N3","#H6N3-H6N3F1","#H5N2-H6N2","#H5N3S1-H5N4S1","#H5N3-H6N3","#H5N2-H5N2F1","#H5N3-H5N3F1"],"structures":["1443"],"references":["2990"]},{"id":"628","glytoucanId":"G82463GQ","glyconnectFormat":"Hex:5 HexNAc:3 NeuAc:1","byonicFormat":"HexNAc(3)Hex(5)NeuAc(1)","condensedFormat":"H5N3S1","averageMass":1729.5702,"monoisotopicMass":1728.6082,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":3,"childCount":3,"parents":["#H5N2-H5N2S1","#H5N3-H5N3S1","#H5N2S1-H5N3S1","#H5N2-H5N3"],"children":["#H5N4S1-H5N4F1S1","#H5N3S1-H6N3S1","#H5N3S1-H5N4S1"],"structures":["11125"],"references":["2990"]},{"id":"691","glytoucanId":"G64527OM","glyconnectFormat":"Hex:8 HexNAc:2","byonicFormat":"HexNAc(2)Hex(8)","condensedFormat":"H8N2","averageMass":1721.5445,"monoisotopicMass":1720.5918,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":3,"childCount":1,"parents":["#H7N2-H8N2","#H6N2-H7N2","#H5N2-H6N2"],"children":["#H8N2-H9N2"],"structures":["362"],"references":["2990"]},{"id":"742","glytoucanId":"G49874UX","glyconnectFormat":"Hex:3 HexNAc:4 dHex:1","byonicFormat":"HexNAc(4)Hex(3)dHex(1)","condensedFormat":"H3N4F1","averageMass":1463.3655,"monoisotopicMass":1462.5445,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":1,"childCount":7,"parents":["#H3N4-H3N4F1"],"children":["#H4N5F1-H4N5F2","#H5N4F1-H5N4F1S1","#H4N5F1-H5N5F1","#H4N4F1-H5N4F1","#H4N4F1-H4N5F1","#H5N4F1-H5N5F1","#H3N4F1-H4N4F1","#H4N5F1-H4N5F1S1"],"structures":["2967"],"references":["2990"]},{"id":"762","glytoucanId":"G84820NF","glyconnectFormat":"Hex:6 HexNAc:3 dHex:1","byonicFormat":"HexNAc(3)Hex(6)dHex(1)","condensedFormat":"H6N3F1","averageMass":1746.5977,"monoisotopicMass":1745.6235,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":6,"childCount":0,"parents":["#H5N2F1-H5N3F1","#H6N2-H6N3","#H5N2-H5N3","#H6N3-H6N3F1","#H5N2-H6N2","#H5N3-H6N3","#H5N2-H5N2F1","#H5N3F1-H6N3F1","#H5N3-H5N3F1"],"children":[],"structures":["11109"],"references":["2990"]},{"id":"603","glytoucanId":"G39188ZX","glyconnectFormat":"Hex:6 HexNAc:2","byonicFormat":"HexNAc(2)Hex(6)","condensedFormat":"H6N2","averageMass":1397.2597,"monoisotopicMass":1396.4862,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":1,"childCount":6,"parents":["#H5N2-H6N2"],"children":["#H8N2-H9N2","#H7N2-H8N2","#H6N2-H7N2","#H6N2-H6N3","#H6N3-H6N3F1","#H6N3-H6N3S1"],"structures":["2039"],"references":["2990"]},{"id":"649","glytoucanId":"G70101JE","glyconnectFormat":"Hex:9 HexNAc:2","byonicFormat":"HexNAc(2)Hex(9)","condensedFormat":"H9N2","averageMass":1883.6869,"monoisotopicMass":1882.6446,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":4,"childCount":0,"parents":["#H8N2-H9N2","#H7N2-H8N2","#H6N2-H7N2","#H5N2-H6N2"],"children":[],"structures":["2472"],"references":["2990"]},{"id":"558","glytoucanId":"G72735IY","glyconnectFormat":"Hex:6 HexNAc:3","byonicFormat":"HexNAc(3)Hex(6)","condensedFormat":"H6N3","averageMass":1600.4547,"monoisotopicMass":1599.5656,"label":"A","glycanType":"N-Linked","virtual":false,"parentCount":3,"childCount":2,"parents":["#H6N2-H6N3","#H5N2-H5N3","#H5N2-H6N2","#H5N3-H6N3"],"children":["#H6N3-H6N3F1","#H6N3-H6N3S1"],"structures":["70"],"references":["2990"]},{"id":"","glytoucanId":"","glyconnectFormat":"Hex:5 HexNAc:2 dHex:1","condensedFormat":"H5N2F1","averageMass":0.0,"monoisotopicMass":0.0,"label":"Virtual","glycanType":"Unknown","virtual":true,"parentCount":1,"childCount":5,"parents":["#H5N2-H5N2F1"],"children":["#H5N4F1-H5N4F1S1","#H5N3F1-H5N4F1","#H5N2F1-H5N3F1","#H5N4F1-H5N5F1","#H5N3F1-H6N3F1"],"structures":[],"references":[]},{"id":"","glytoucanId":"","glyconnectFormat":"Hex:5 HexNAc:3","condensedFormat":"H5N3","averageMass":0.0,"monoisotopicMass":0.0,"label":"Virtual","glycanType":"Unknown","virtual":true,"parentCount":1,"childCount":9,"parents":["#H5N2-H5N3"],"children":["#H5N4F1-H5N4F1S1","#H5N4S1-H5N4F1S1","#H5N3-H5N3S1","#H5N3F1-H5N4F1","#H5N3S1-H6N3S1","#H6N3-H6N3F1","#H5N4F1-H5N5F1","#H5N3S1-H5N4S1","#H6N3-H6N3S1","#H5N3-H6N3","#H5N3F1-H6N3F1","#H5N3-H5N3F1"],"structures":[],"references":[]},{"id":"","glytoucanId":"","glyconnectFormat":"Hex:5 HexNAc:2 NeuAc:1","condensedFormat":"H5N2S1","averageMass":0.0,"monoisotopicMass":0.0,"label":"Virtual","glycanType":"Unknown","virtual":true,"parentCount":1,"childCount":4,"parents":["#H5N2-H5N2S1"],"children":["#H5N4S1-H5N4F1S1","#H5N2S1-H5N3S1","#H5N3S1-H6N3S1","#H5N3S1-H5N4S1"],"structures":[],"references":[]},{"id":"","glytoucanId":"","glyconnectFormat":"Hex:7 HexNAc:2","condensedFormat":"H7N2","averageMass":0.0,"monoisotopicMass":0.0,"label":"Virtual","glycanType":"Unknown","virtual":true,"parentCount":2,"childCount":2,"parents":["#H6N2-H7N2","#H5N2-H6N2"],"children":["#H8N2-H9N2","#H7N2-H8N2"],"structures":[],"references":[]}],"links":[{"source":"H4N5F1","target":"H4N5F2","abbreviation":"dHex","condensedFormat":"F"},{"source":"H4N5F1","target":"H4N5F1S1","abbreviation":"NeuAc","condensedFormat":"S"},{"source":"H4N5F1","target":"H5N5F1","abbreviation":"Hex","condensedFormat":"H"},{"source":"H4N5","target":"H4N5F1","abbreviation":"dHex","condensedFormat":"F"},{"source":"H4N4F1","target":"H4N5F1","abbreviation":"HexNAc","condensedFormat":"N"},{"source":"H4N4F1","target":"H5N4F1","abbreviation":"Hex","condensedFormat":"H"},{"source":"H3N5","target":"H4N5","abbreviation":"Hex","condensedFormat":"H"},{"source":"H3N4","target":"H3N5","abbreviation":"HexNAc","condensedFormat":"N"},{"source":"H3N4","target":"H3N4F1","abbreviation":"dHex","condensedFormat":"F"},{"source":"H5N3F1","target":"H5N4F1","abbreviation":"HexNAc","condensedFormat":"N"},{"source":"H5N3F1","target":"H6N3F1","abbreviation":"Hex","condensedFormat":"H"},{"source":"H5N4F1","target":"H5N4F1S1","abbreviation":"NeuAc","condensedFormat":"S"},{"source":"H5N4F1","target":"H5N5F1","abbreviation":"HexNAc","condensedFormat":"N"},{"source":"H5N4S1","target":"H5N4F1S1","abbreviation":"dHex","condensedFormat":"F"},{"source":"H5N2","target":"H5N2F1","abbreviation":"dHex","condensedFormat":"F"},{"source":"H5N2","target":"H5N3","abbreviation":"HexNAc","condensedFormat":"N"},{"source":"H5N2","target":"H5N2S1","abbreviation":"NeuAc","condensedFormat":"S"},{"source":"H5N2","target":"H6N2","abbreviation":"Hex","condensedFormat":"H"},{"source":"H5N3S1","target":"H6N3S1","abbreviation":"Hex","condensedFormat":"H"},{"source":"H5N3S1","target":"H5N4S1","abbreviation":"HexNAc","condensedFormat":"N"},{"source":"H8N2","target":"H9N2","abbreviation":"Hex","condensedFormat":"H"},{"source":"H3N4F1","target":"H4N4F1","abbreviation":"Hex","condensedFormat":"H"},{"source":"H6N2","target":"H7N2","abbreviation":"Hex","condensedFormat":"H"},{"source":"H6N2","target":"H6N3","abbreviation":"HexNAc","condensedFormat":"N"},{"source":"H6N3","target":"H6N3S1","abbreviation":"NeuAc","condensedFormat":"S"},{"source":"H6N3","target":"H6N3F1","abbreviation":"dHex","condensedFormat":"F"},{"source":"H5N2F1","target":"H5N3F1","abbreviation":"HexNAc","condensedFormat":"N"},{"source":"H5N3","target":"H5N3F1","abbreviation":"dHex","condensedFormat":"F"},{"source":"H5N3","target":"H5N3S1","abbreviation":"NeuAc","condensedFormat":"S"},{"source":"H5N3","target":"H6N3","abbreviation":"Hex","condensedFormat":"H"},{"source":"H5N2S1","target":"H5N3S1","abbreviation":"HexNAc","condensedFormat":"N"},{"source":"H7N2","target":"H8N2","abbreviation":"Hex","condensedFormat":"H"}]}}
